⏱ 4 min read
A precursor is the starting molecule from which the body synthesizes another substance. The logic is simple and powerful: if you provide the right building block —usually an amino acid, a fatty acid, or a specific nutrient—, you give the body the raw material to make the final compound, whether it is a neurotransmitter, a hormone, an active vitamin, or an energy metabolite. Many supplementation strategies rest on this idea: the end product is not administered (it often does not cross the body's barriers well or is degraded), but its precursor, letting the enzymatic machinery do the rest.
But there is a nuance that separates theory from practice: synthesis is regulated. Between the precursor and the product there is almost always a rate-limiting enzyme —a bottleneck— and some cofactors without which the reaction does not advance. Tyrosine hydroxylase, tryptophan hydroxylase, or glutamate decarboxylase need tetrahydrobiopterin (BH4), iron, or vitamin B6 to function; if the cofactor is missing, providing more precursor does not increase the product. That is why this map groups precursors by what they produce and, in each profile, points out both the pathway and the step that really rules.
The paradigmatic case is dopamine. Its synthesis starts from tyrosine, but the enzyme that sets the pace —tyrosine hydroxylase— is subject to end-product inhibition: when there is enough dopamine, dopamine itself brakes the enzyme. Providing extra tyrosine raises production only when demand is high (acute stress, sleep deprivation, intense cognitive effort) or when there is a real deficit; in a healthy, rested brain, the effect is marginal. The same logic of feedback regulation governs serotonin, NAD synthesis from tryptophan, and hormone production from cholesterol.
Cofactors are the vitamins and minerals that enzymes need to catalyze each step. The decarboxylation that converts 5-HTP into serotonin and glutamate into GABA depends on pyridoxal phosphate (active vitamin B6); the conversion of tyrosine and tryptophan into their products requires BH4, which in turn depends on folate and on the enzyme that recycles it; the synthesis of catecholamine neurotransmitters needs iron and copper. In clinical practice, a subtle deficiency of these cofactors explains why two people respond very differently to the same precursor: the raw material is not enough if the tool that transforms it is missing.
Each precursor family has its own page with the biochemical pathway, the rate-limiting enzyme, the cofactors involved, which supplements provide each precursor, and what the evidence says about their real usefulness. The general rule worth keeping in mind: precursors work best when they correct a deficiency or meet a high demand, and less well when the system is already saturated and well regulated. They are not magic shortcuts, but raw material for a machinery that decides on its own how much to make.
Educational information, not medical advice.